- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06455982
Reduced Carbohydrates + Ketogenic Supplement on Energy Metabolism (SAGE-2)
June 6, 2024 updated by: Université de Sherbrooke
Effect of a Reduced Carbohydrates Menu Combined With a Ketogenic Supplement on Energy Metabolism in a Senior Residence: the SAGE-2 Study
The present study will evaluate the effects on glucose, ketones and other blood biomarkers, cognition, quality of life, physical activity and well-being of a reduced carbohydrate diet paired with a ketogenic product for 2 months in a population living in a senior residence.
This study follows the KetoHome (fall 2022) and SAGE (fall 2023) projects which assessed the feasibility, acceptability and effectiveness of a reduced carbohydrate intervention alone.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Camille Vandenberghe
- Phone Number: 45235 819-780-2220
- Email: camille.vandenberghe@usherbrooke.ca
Study Locations
-
-
Quebec
-
Sherbrooke, Quebec, Canada, J1H 4C4
- Centre de recherche sur le vieillissement
-
Contact:
- Camille Vandenberghe, M.Sc
- Phone Number: 45235 819-780-2220
- Email: camille.vandenberghe@usherbrooke.ca
-
Principal Investigator:
- Stephen C Cunnane, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Older men or women in a senior residence;
- Understand, read and write French;
- Have sufficient visual and hearing acuity to pass cognitive tests;
- Available during the intervention period
Exclusion Criteria:
- Body mass index < 20;
- T1 diabetic;
- T2 insulin-dependent diabetic;
- MMSE < 20;
- Weight loss >10% in the last 6 months involuntary or voluntary;
- Known and uncontrolled hypoglycemia;
- Moderate to severe digestive illnesses that can be aggravated by dietary changes;
- Severe dysphagia;
- Supplementation with MCT oil, ketone salts, ketone esters, adherence to the ketogenic diet, reduced carbohydrate diet, intermittent fasting or other diet or supplements that can significantly increase ketones in the last month;
- Participation in other interventional research projects on nutrition or aimed at metabolic change simultaneously.
- Medical condition that could prevent the participant from completing the study in the opinion of the doctor
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Delta of before/after the intervention
2 months of reduced carbohydrate menu combined with a ketogenic MCT supplement
|
Participants will eat a reduced carb menu for 2 months and they will take 15g of MCT in the morning and the evening for a total of 30g per day.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma glucose concentration
Time Frame: 2 months
|
To evaluate the possible improvement in mean glucose concentration following a reduction in carbohydrates combined with an MCT supplement in people living in a senoir residence for 2 months.
|
2 months
|
|
Plasma ketones concentration
Time Frame: 2 months
|
To evaluate the possible improvement in mean ketones concentration following a reduction in carbohydrates combined with an MCT supplement in people living in a senoir residence for 2 months.
|
2 months
|
|
Plasma insulin concentration
Time Frame: 2 months
|
To evaluate the possible improvement in mean insulin concentration following a reduction in carbohydrates combined with an MCT supplement in people living in a senoir residence for 2 months.
|
2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma triglycerides concentration
Time Frame: 2 months
|
To evaluate the possible improvement in mean triglycerides concentration following a reduction in carbohydrates combined with an MCT supplement in people living in a senoir residence for 2 months.
|
2 months
|
|
Plasma cholesterol concentration
Time Frame: 2 months
|
To evaluate the possible improvement in mean cholesterol concentration following a reduction in carbohydrates combined with an MCT supplement in people living in a senoir residence for 2 months.
|
2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
September 5, 2024
Primary Completion (Estimated)
December 15, 2024
Study Completion (Estimated)
December 15, 2025
Study Registration Dates
First Submitted
June 6, 2024
First Submitted That Met QC Criteria
June 6, 2024
First Posted (Actual)
June 13, 2024
Study Record Updates
Last Update Posted (Actual)
June 13, 2024
Last Update Submitted That Met QC Criteria
June 6, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2025-5533
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Aging
-
Florida Institute for Human and Machine CognitionNot yet recruitingAging | Healthy Aging | Aging WellUnited States
-
Centre Hospitalier Universitaire de NiceNot yet recruitingAging | Aging, HealthyFrance
-
University of CopenhagenRecruitingAging | Healthy Aging | Aging FrailtyDenmark
-
Arizona State UniversityActive, not recruiting
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
Beijing HospitalBGI-ShenzhenCompletedAging | Healthy Aging
-
Synbiotic HealthMusB ResearchRecruitingHealthy Aging | Anti AgingUnited States
-
Research Centre for Natural SciencesSemmelweis University; HUN-REN Institute of Experimental MedicineActive, not recruitingHealthy Aging | Neurocognitive AgingHungary
-
Northumbria UniversityUniversity of East AngliaSuspendedSleep | Aging | Healthy AgingUnited Kingdom
Clinical Trials on reduced carbohydrate menu combined with ketogenic supplement
-
Robert C. Atkins FoundationCompletedObesity | Overweight | Type 2 Diabetes MellitusUnited States
-
Ohio State UniversityRecruitingPCOS (Polycystic Ovary Syndrome)United States
-
Université de SherbrookeNestle Health ScienceCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Wroclaw Medical UniversityCompleted
-
Universitaet InnsbruckTirol Kiniken GmbHCompletedSmoking Cessation | Healthy | Healthy Lifestyle | Intermittent FastingAustria
-
Karolinska University HospitalKarolinska Institutet; Fingers Brain Health Institute; af Jochnick FoundationRecruitingNeurocognitive Disorders | Alzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's DiseaseSweden
-
Texas Woman's UniversityCompleted
-
University of JordanCompletedThe Effect of Ketogenic-caloric Restricted Diet on Metabolic Endotoxemia in Prediabetic Obese AdultsObesity | Insulin Resistance | Prediabetes | Ketogenic Diet | Caloric Restriction | Metabolic Endotoxemia | Inflammation BiomarkersJordan
-
Longhao LiNot yet recruiting